Granted
The Board granted a higher rating of 100 percent for the Veteran's skin cancer due to ongoing antineoplastic chemotherapy and immunotherapy.
The deciding factor: The evidence supports that the Veteran is undergoing treatment comparable to systemic malignancies, which meets the criteria for a 100 percent evaluation under DC 7818.
- Claimed conditions
- squamous cell carcinoma with residual scar
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 100%
- Decision date
- March 11, 2025
- Citation
- A25022036
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.